Literature DB >> 11085940

Mouse pseudouridine synthase 1: gene structure and alternative splicing of pre-mRNA.

J Chen1, J R Patton.   

Abstract

Evidence for the alternative splicing of the message for mouse pseudouridine synthase 1 (mPus1p) was found when several expressed sequence tag clones were completely sequenced. The genomic DNA for the MPUS1 gene (6.9 kb) was cloned from a mouse genomic library; the gene contains seven exons, of which three are alternatively spliced. In addition, one of the internal exons (exon VI) is unusually large. RNase protection analysis confirmed that several alternatively spliced messages were present in mouse tissues and cells in culture. A Western blot of total cellular protein from mouse tissues and cultured cells was reacted with an antibody specific for mPus1p; at least three proteins were detected. One protein corresponds to the predicted molecular mass of mPus1p (44 kDa) and is the most abundant. The two other isoforms, one 2 kDa larger and one 7 kDa smaller than mPus1p, were differentially expressed. The cDNA species for the three isoforms were cloned into expression plasmids; the proteins were synthesized in vitro and tested for pseudouridine synthase activity. The two isoforms, one containing an insert of 18 amino acids in a region of the enzyme assumed to be critical for activity, and the other, which has a deletion of the protein coding potential of two exons, were both inactive on tRNA substrates that mPus1p modifies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085940      PMCID: PMC1221478     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  The structural basis for tRNA recognition and pseudouridine formation by pseudouridine synthase I.

Authors:  P G Foster; L Huang; D V Santi; R M Stroud
Journal:  Nat Struct Biol       Date:  2000-01

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Purification, structure, and properties of Escherichia coli tRNA pseudouridine synthase I.

Authors:  H O Kammen; C C Marvel; L Hardy; E E Penhoet
Journal:  J Biol Chem       Date:  1988-02-15       Impact factor: 5.157

Review 4.  Minor components in transfer RNA: their characterization, location, and function.

Authors:  S Nishimura
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1972

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Transfer RNA modification.

Authors:  G R Björk; J U Ericson; C E Gustafsson; T G Hagervall; Y H Jönsson; P M Wikström
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

7.  Cloning and characterization of a mammalian pseudouridine synthase.

Authors:  J Chen; J R Patton
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

8.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

9.  In vitro biosynthesis of pseudouridine at the polynucleotide level by an enzyme extract from Escherichia coli.

Authors:  L Johnson; D Söll
Journal:  Proc Natl Acad Sci U S A       Date:  1970-10       Impact factor: 11.205

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  8 in total

1.  Pleiotropic effects and compensation mechanisms determine tissue specificity in mitochondrial myopathy and sideroblastic anemia (MLASA).

Authors:  Yelena Bykhovskaya; Emebet Mengesha; Nathan Fischel-Ghodsian
Journal:  Mol Genet Metab       Date:  2007-03-19       Impact factor: 4.797

2.  Caenorhabditis elegans pseudouridine synthase 1 activity in vivo: tRNA is a substrate, but not U2 small nuclear RNA.

Authors:  Jeffrey R Patton; Richard W Padgett
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

3.  Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA).

Authors:  Yelena Bykhovskaya; Kari Casas; Emebet Mengesha; Aida Inbal; Nathan Fischel-Ghodsian
Journal:  Am J Hum Genet       Date:  2004-04-22       Impact factor: 11.025

4.  Partial activity is seen with many substitutions of highly conserved active site residues in human Pseudouridine synthase 1.

Authors:  Bryan S Sibert; Nathan Fischel-Ghodsian; Jeffrey R Patton
Journal:  RNA       Date:  2008-07-22       Impact factor: 4.942

5.  Formation of a stalled early intermediate of pseudouridine synthesis monitored by real-time FRET.

Authors:  Martin Hengesbach; Felix Voigts-Hoffmann; Benjamin Hofmann; Mark Helm
Journal:  RNA       Date:  2010-01-27       Impact factor: 4.942

6.  Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA).

Authors:  Erika Fernandez-Vizarra; Angela Berardinelli; Lucia Valente; Valeria Tiranti; Massimo Zeviani
Journal:  J Med Genet       Date:  2006-10-20       Impact factor: 6.318

7.  Pseudouridine synthase 1: a site-specific synthase without strict sequence recognition requirements.

Authors:  Bryan S Sibert; Jeffrey R Patton
Journal:  Nucleic Acids Res       Date:  2011-11-18       Impact factor: 16.971

8.  Pseudouridine synthase 1 deficient mice, a model for Mitochondrial Myopathy with Sideroblastic Anemia, exhibit muscle morphology and physiology alterations.

Authors:  Joshua E Mangum; Justin P Hardee; Dennis K Fix; Melissa J Puppa; Johnathon Elkes; Diego Altomare; Yelena Bykhovskaya; Dean R Campagna; Paul J Schmidt; Anoop K Sendamarai; Hart G W Lidov; Shayne C Barlow; Nathan Fischel-Ghodsian; Mark D Fleming; James A Carson; Jeffrey R Patton
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.